Yabao Pharmaceutical Group Co (SHSE:600351) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Yabao Pharmaceutical Group Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Yabao Pharmaceutical Group Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.00.

Yabao Pharmaceutical Group Co's long-term debt to total assets ratio declined from Mar. 2023 (0.00) to Mar. 2024 (0.00). It may suggest that Yabao Pharmaceutical Group Co is progressively becoming less dependent on debt to grow their business.

Yabao Pharmaceutical Group Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Yabao Pharmaceutical Group Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yabao Pharmaceutical Group Co LT-Debt-to-Total-Asset Chart

Yabao Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

Yabao Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Yabao Pharmaceutical Group Co LT-Debt-to-Total-Asset Calculation

Yabao Pharmaceutical Group Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	3.369	/	3853.637
	=	0.00

Yabao Pharmaceutical Group Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	1.276	/	3797.111
	=	0.00

Yabao Pharmaceutical Group Co (SHSE:600351) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Yabao Pharmaceutical Group Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Yabao Pharmaceutical Group Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Yabao Pharmaceutical Group Co (SHSE:600351) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yabao Pharmaceutical Group Co Ltd (SHSE:600351) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

No.43 Fumin Road, Ruicheng, Shanxi Province, Yuncheng, CHN, 044602

Website

http://www.yabao.com.cn

Yabao Pharmaceutical Group Co Ltd is engaged in the manufacture and operation of western and Chinese medicines, APIs, health care products, packing materials for medicine, and also engages in the planting and processing of medicinal herbs.

Yabao Pharmaceutical Group Co (SHSE:600351) Headlines

No Headlines